menu search

Molecular Templates, Inc. Reports Fourth Quarter 2022 Financial Results and Business Update

Molecular Templates, Inc. Reports Fourth Quarter 2022 Financial Results and Business Update
Announces strategic reprioritization to focus on clinical development of MT-6402, MT-8421, and MT-0169, and preclinical activities related to BMS collaboration, and related workforce reduction AUSTIN, Texas, March 30, 2023 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, […] The post Molecular Templates, Inc. Reports Four... Read More
Posted: Mar 30 2023, 22:10
Author Name: forextv
Views: 082151

Search within

Pages Search Results: